@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix rdf: . @prefix infores: . @prefix xsd: . @prefix umls: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "ACE."; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "ACE inhibitor"; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "valsartan"; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "Sacubitril"; biolink:category biolink:ChemicalEntity . umls:C0264716 a biolink:DiseaseOrPhenotypicFeature; rdfs:label "chronic heart failure"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "heart failure"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:ChemicalEntity; rdfs:label "ARB"; biolink:category biolink:ChemicalEntity . sub:_1 rdf:object umls:C0264716; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_2 rdf:object umls:C0264716; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_3 rdf:object ; rdf:predicate biolink:associated_with; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_4 rdf:object ; rdf:predicate biolink:interacts_with; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_5 rdf:object ; rdf:predicate biolink:interacts_with; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-13T12:47:09.419174"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom " Sacubitril is used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB. It is also used in. combination with. an ACE. inhibitor or an ARB, it is usually used in conjunction." . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "LhvkwltbAzmm++ksEk38cqRyE7GlRQawJku8ZxhUYF8oeLaniDMSLBxg6So3vEUnP9Txc3uUY+17yRwssgbPkvxJ+liwMdaNIh7HecakOdX7a78fqaJ1zNjwloYFVnnk/RgFR6YeoqNFdgmZms6HsqJlkQUNseK1Iy4Bhg/P+thzaGlB5P+Qea6gD3eBLGGbPsqJTxzjF4WomdRuz4dC8/YEGVKXnZOyqmAnpSHo5cg+02Sm/r0OH8aYLxNuGpXS2YDDdB7Ty3we2J6fTDOmTwKJeMqPeC4ZILdZX0n7LWUr2+QJ8J3aIpBX1SHXWYCemnof1p0cCwDMjwk1BFlXoA=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-13T12:47:09.419174"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }